$633 Million is the total value of Bronte Capital Management Pty Ltd.'s 15 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 15.4% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b new | $113,951,000 | +14.0% | 491,444 | -0.8% | 18.00% | +2.3% |
HLF | HERBALIFE NUTRITION LTD | $99,043,000 | +6.4% | 2,061,245 | 0.0% | 15.65% | -4.5% | |
IBKR | Sell | INTERACTIVE BROKERS GROUP | $78,541,000 | +26.5% | 1,289,241 | -1.2% | 12.41% | +13.5% |
V | Sell | VISA INC | $68,340,000 | -5.5% | 312,438 | -21.5% | 10.80% | -15.2% |
IWM | New | ISHARES TRcall | $59,246,000 | – | 30,000 | +100.0% | 9.36% | – |
SPY | SPDR S&P 500 ETF TRcall | $56,341,000 | +11.7% | 15,000 | 0.0% | 8.90% | +0.2% | |
CTVA | CORTEVA NC | $32,359,000 | +17.4% | 835,714 | 0.0% | 5.11% | +5.3% | |
GOOG | ALPHABET INCcap stk cl c | $23,488,000 | 0.0% | 14,490 | 0.0% | 3.71% | -10.3% | |
GOOGL | Sell | ALPHABET INCcap stk cl a | $22,049,000 | -71.1% | 12,586 | -73.3% | 3.48% | -74.1% |
BK | Sell | BANK NEW YORK MELLON CORP | $20,385,000 | +21.1% | 480,315 | -2.0% | 3.22% | +8.6% |
NEM | Sell | NEWMONT CORP | $19,870,000 | -17.0% | 331,769 | -12.9% | 3.14% | -25.5% |
STT | Sell | STATE STR CORP | $19,180,000 | +20.2% | 263,537 | -2.8% | 3.03% | +7.8% |
REGN | New | REGENERON PHARMACEUTICALS | $9,205,000 | – | 19,053 | +100.0% | 1.45% | – |
GHC | Buy | GRAHAM HLDGS CO | $7,248,000 | +87.4% | 13,588 | +33.6% | 1.14% | +68.1% |
MACK | MERRIMACK PHARMACEUTICALS IN | $3,662,000 | +78.5% | 531,510 | 0.0% | 0.58% | +60.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-03
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
CORTEVA NC | 17 | Q3 2023 | 6.2% |
GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
SCHEDULE 13G | 2024-02-13 |
13F-HR | 2024-02-07 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-03 |
13F-HR/A | 2022-08-08 |
13F-HR | 2022-08-08 |
13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.